BPC 157
Janoshik
Batch BPC-CA-26A-02
BPC-157 Capsules
Recovery Compound
BPC-157 is a synthetic peptide studied in research settings for its activity within cellular signaling pathways associated with structural tissue and recovery processes. Studies involving this format often examine peptide stability, absorption dynamics, and how peptides interact with systemic biochemical signaling pathways.
🔬 This product is coming soon — ordering is not yet available.
This product is intended strictly for laboratory research use within the United States. It is not approved by the FDA for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable U.S. federal, state, and local regulations.
BPC-157 is a synthetic peptide sequence derived from a protective gastric protein fragment. It is developed for controlled laboratory research involving cellular signaling and tissue response models.
In scientific literature, BPC-157 is investigated in experimental frameworks examining angiogenic pathways, inflammatory modulation systems, and cytoskeletal regulatory mechanisms under in vitro and preclinical research conditions.
BPC-157 is evaluated in research focused on peptide-mediated cellular signaling and recovery-related pathway systems. Experimental studies examine its interaction with angiogenic signaling frameworks, inflammatory regulatory mechanisms, and extracellular matrix–associated pathways within controlled laboratory environments.
Research publications have explored its role in tissue response models and pathway-level signaling interaction under structured experimental conditions.
BPC-157 originated from investigations into biologically active fragments of gastric protective proteins. Laboratory research expanded into studies exploring its signaling behavior and interaction with cellular regulatory systems.
Subsequent experimental models examined its pathway-level activity in connective tissue and vascular-related research frameworks.
Laboratory investigations into BPC-157 have focused on cellular signaling models and peptide-mediated regulatory systems. Research frameworks evaluate angiogenic pathway interaction, inflammatory signaling modulation, and cytoskeletal regulatory mechanisms under controlled in vitro and preclinical conditions.
0 of the 4 areas below are addressed directly by a paper cited on this page.
Angiogenic pathway models
No paper cited on this page reports on angiogenic. This heading marks where BPC-157 Capsules is discussed in the category rather than a question the cited literature answers, and it is worth knowing which of these areas has work behind it and which does not.
Inflammatory signaling system studies
No paper cited on this page reports on inflammatory. This heading marks where BPC-157 Capsules is discussed in the category rather than a question the cited literature answers, and it is worth knowing which of these areas has work behind it and which does not.
Cytoskeletal regulatory framework research
No paper cited on this page reports on cytoskeletal. This heading marks where BPC-157 Capsules is discussed in the category rather than a question the cited literature answers, and it is worth knowing which of these areas has work behind it and which does not.
Extracellular matrix interaction investigations
No paper cited on this page reports on extracellular, matrix or interaction. This heading marks where BPC-157 Capsules is discussed in the category rather than a question the cited literature answers, and it is worth knowing which of these areas has work behind it and which does not.
The references section of this page cites 8 primary papers published between 1993 and 2020 — a reasonably developed body of work for a research compound. Every citation is linked to its PubMed or DOI record so it can be read rather than taken on trust, and the summaries above describe what those papers report rather than what the compound is claimed to do.
Research compounds attract claims that outrun their evidence. Below are the ones most often encountered for BPC-157 Capsules, set against what the papers cited on this page actually report. Where the record is thin or contested, that is stated rather than smoothed over.
BPC-157 Capsules is also referred to as BPC, body protection compound, the wolverine peptide.
BPC-157 Capsules is commonly described online in connection with faster healing from injury and improved recovery. In the research literature the same compound is filed under angiogenic pathway models, inflammatory signaling system studies and cytoskeletal regulatory framework research.
The 8 papers cited on this page, published between 1993 and 2020 (4 in animal models and 1 review) describe laboratory and animal work. None reports a controlled trial in humans. Findings in cell culture or in a rodent model describe what happened in that system; they do not establish that the same occurs in humans, and this compound is not approved for human use.
Nothing above is a statement of what this material does. It is a summary of what has been published and what has not. Eppix Labs supplies research materials only and provides no dosing, administration or protocol guidance.
The lot code printed on the bottle matches the code on the certificate for BPC-157 Capsules. Matching the two is what confirms the unit in hand came from the batch that was tested — a certificate not tied to a lot code proves nothing about any particular unit.
Researchers who buy BPC-157 Capsules in the United States through Eppix Labs receive the lot described by the certificate above: the code printed on the vial label is the code on the certificate, and both are searchable on the batch verification page.
- Storage
- Cool, dry, away from direct light
- Humidity
- Keep sealed; capsule shells are hygroscopic
- Reconstitution
- Not applicable — supplied pre-measured
- Format
- Oral capsule
BPC-157 Capsules is supplied in capsule form, which removes the reconstitution step entirely: there is no vehicle to add, no reconstitution volume to record and no post-reconstitution stability window to track. What that leaves a laboratory to control is storage — capsule shells draw moisture from the air, so the container should be kept sealed and dry rather than decanted into an open vessel.
Because the material is already at its labelled quantity per capsule, batch verification carries more weight in this format than it does for powder: there is no point at which the researcher independently confirms mass by weighing. The measured content published for each lot is the figure that answers that question.
- 1 × sealed capsule bottle (500 mcg per capsule / Single Bottle - Pack of 60), batch-labelled
- The batch-linked Certificate of Analysis for the exact lot shipped
- Discreet outer packaging with no product names on the exterior
- FedEx, tracked, typically 1–3 business days domestically
- Laboratory consumables of any kind
- Dosing, administration or protocol guidance of any kind
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each capsule contains the labeled quantity of BPC-157. Independent third-party testing verifies purity, identity, and batch specifications prior to release.
The product is supplied in capsule form for laboratory research purposes. No additional materials are included.
Duration depends entirely on research protocol, storage conditions, and laboratory application.
A new gastric juice peptide, BPC. An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC. J Physiol Paris 87(5):313–327.
PubMedGastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res 21(6):976–983.
PubMedThe promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol (1985) 110(3):774–780.
PubMedBody protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro. Drug Des Devel Ther 9:2485–2499.
PubMedModulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway. Sci Rep 10(1):17078.
PubMedStable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights. World J Gastroenterol 23(48):8465–8488.
PubMedThe effect of pentadecapeptide BPC 157 on hippocampal ischemia/reperfusion injuries in rats. Brain Behav 10(8):e01726.
PubMedPentadecapeptide BPC 157 resolves Pringle maneuver in rats, both ischemia and reperfusion. World J Hepatol 12(5):184–206.
PubMedRelated
You May Also Like
Next-generation GLP receptor agonist studied for metabolic signaling and nutrient partitioning pathways
From$79.99
Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$39.99
Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$59.99
Long-acting amylin analog engineered for appetite signaling, metabolic control, and energy balance research
From$99.99